[HTML][HTML] Multifaceted role of neuropilins in the immune system: potential targets for immunotherapy

S Roy, AK Bag, RK Singh, JE Talmadge… - Frontiers in …, 2017 - frontiersin.org
Neuropilins (NRPs) are non-tyrosine kinase cell surface glycoproteins expressed in all
vertebrates and widely conserved across species. The two isoforms, such as neuropilin-1 …

[HTML][HTML] Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer

M Ashrafizadeh, K Hushmandi, E Rahmani Moghadam… - Bioengineering, 2020 - mdpi.com
Prostate cancer (PCa) accounts for a high number of deaths in males with no available
curative treatments. Patients with PCa are commonly diagnosed in advanced stages due to …

[HTML][HTML] Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis

ZD Nassar, CY Mah, J Dehairs, IJG Burvenich, S Irani… - Elife, 2020 - elifesciences.org
Fatty acid β-oxidation (FAO) is the main bioenergetic pathway in human prostate cancer
(PCa) and a promising novel therapeutic vulnerability. Here we demonstrate therapeutic …

[HTML][HTML] MicroRNAs in cancer metastasis and angiogenesis

W Lou, J Liu, Y Gao, G Zhong, D Chen, J Shen, C Bao… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cancer metastasis is a malignant process by which tumor cells migrate from their primary
site of origin to other organs. It is the main cause of poor prognosis in cancer patients …

[HTML][HTML] NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation

P Zhang, L Chen, F Zhou, Z He, G Wang, Y Luo - Cell Death & Disease, 2023 - nature.com
Prostate cancer (PCa) is the most common malignant tumor with a high global incidence in
males. The mechanism underlying PCa progression is still not clear. This study observed …

[HTML][HTML] Neuropilins in the context of tumor vasculature

S Niland, JA Eble - International journal of molecular sciences, 2019 - mdpi.com
Neuropilin-1 and Neuropilin-2 form a small family of plasma membrane spanning receptors
originally identified by the binding of semaphorin and vascular endothelial growth factor …

[HTML][HTML] Myeloid checkpoints for cancer immunotherapy

Y Qian, T Yang, H Liang, M Deng - Chinese Journal of Cancer …, 2022 - ncbi.nlm.nih.gov
Myeloid checkpoints are receptors on the myeloid cell surface which can mediate inhibitory
signals to modulate anti-tumor immune activities. They can either inhibit cellular …

[HTML][HTML] Prostate cancer genetic risk and associated aggressive disease in men of African ancestry

PXY Soh, N Mmekwa, DC Petersen, K Gheybi… - Nature …, 2023 - nature.com
African ancestry is a significant risk factor for prostate cancer and advanced disease. Yet,
genetic studies have largely been conducted outside the context of Sub-Saharan Africa …

[HTML][HTML] Neuropilin (NRPs) related pathological conditions and their modulators

M Broz, A Kolarič, M Jukič, U Bren - International journal of molecular …, 2022 - mdpi.com
Neuropilin 1 (NRP1) represents one of the two homologous neuropilins (NRP, splice
variants of neuropilin 2 are the other) found in all vertebrates. It forms a transmembrane …

[HTML][HTML] The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer

C Blanc, A Moktefi, A Jolly, P De La Grange… - British Journal of …, 2023 - nature.com
Background Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in clinics. Understanding the …